Recurrence Risk Evaluation by 21-gene Detection

NCT03841266 · clinicaltrials.gov ↗
COMPLETED
Status
220
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Xijing Hospital